
|Articles|September 13, 2012
Tissue-sparing laser therapy
Iridex have launched a non-invasive, in-office glaucoma procedure based on the MicroPulse technology.
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina 2025: Long-term follow-up in paediatric gene therapy
2
Macular laser picks up speed: The technology accelerating retinal therapies
3
FLORetina 2025: Antithrombotic use examined in wet AMD submacular hemorrhage
4
FLORetina 2025: EU-ROP Registry bridges borders for real-world insight
5












































